22/07/2014 - 21:35
NEW YORK – There appears to be progress in the effort to convince the Food and Drug Administration that nonradiologic axial spondyloarthritis is a viable disease entity that deserves to be the target...
Field of Interest: Rheumatology
Categories:
News Feed: Internal Medicine News - Rheumatology